p.83 抽出テキスト
CLINICAL STATEMENTS AND GUIDELINES Circulation. 2023;148:e9–e119. DOI: 10.1161/CIR.0000000000001168 August 29, 2023 Virani et al 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Chronic Coronary Disease Guideline 22 Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplemen- tation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338–1347. 23. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646. 24. Lopez-Sendon J, Purcell H, Camici P, et al. Chronic stable angina guidelinesis there an emerging international consensus?. Br J Card. 2012;19(suppl 2):S2–S11. 25. Jeong SY, Kovell L, Plante TB, et al. Effects of diet on 10-year atherosclerotic cardiovascular disease risk using the pooled cohort equations risk calculator: results from the Dash trial. Circulation. 2021;143(suppl 1):A024. 26. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–477. 27. Alderman MH, Davis BR, Piller LB, et al. Should antihypertensive treatment recommendations differ in patients with and without coronary heart disease? (From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]). Am J Cardiol. 2016;117:105–115. 28. Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146:e18–e43. 29. Van Horn L, Ning H, Steffen L, et al. Dietary factors associated with cardiovascular outcomes: 25 year findings from the coronary artery risk development in young adults (CARDIA) study. Circulation. 2017;135:AMP069. 30. Van Horn L, Carson JAS, Appel LJ, et al. Recommended dietary pattern to achieve adherence to the American Heart Association/American College of Cardiology (AHA/ACC) guidelines: a scientific statement from the American Heart Association. Circulation. 2016;134:e505–e529. 31. Kris-Etherton PM, Lichtenstein AH, Howard BV, et al. Antioxidant vitamin supplements and cardiovascular disease. Circulation. 2004;110:637–641. 32. National Institutes of Health, Office of Dietary Supplememts. Dietary supplements: what you need to know. Accessed October 10, 2021. https://ods. od.nih.gov/factsheets/WYNTK-Consumer/. 33. Singh RB, Rastogi SS, Verma R, et al. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ. 1992;304:1015–1019. 34. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378:e34. 35. Arnold SV, Bhatt DL, Barsness GW, et al. Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2020;141:e779–e806. 36. Trichopoulou A, Costacou T, Bamia C, et al. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348:2599– 2608. 37. Satija A, Bhupathiraju SN, Spiegelman D, et al. Healthful and unhealthful plant-based diets and the risk of coronary heart disease in U.S. adults. J Am Coll Cardiol. 2017;70:411–422. 38. Griel AE, Ruder EH, Kris-Etherton PM. The changing roles of dietary carbohydrates. Arterioscler Thromb Vasc Biol. 2006;26:1958–1965. 39. Reynolds A, Mann J, Cummings J, et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019;393:434–445. 40. Sacks FM, Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med. 2002;113(suppl 9B):13S–24S. 41. Whelton PK, Appel LJ, Sacco RL, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126:2880–2889. 42. Juraschek SP, Kovell LC, Appel LJ, et al. Effects of diet and sodium reduction on cardiac injury, strain, and inflammation: The DASH-Sodium Trial. J Am Coll Cardiol. 2021;77:2625–2634. 43. Anderson CA, Appel LJ, Okuda N, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc. 2010;110:736– 745. 44. Frank SM, Jaacks LM, Batis C, et al. Patterns of red and processed meat consumption across North America: a nationally representative cross-sectional comparison of dietary recalls from Canada, Mexico, and the United States. Int J Environ Res Public Health. 2021;18:357. 45 Pacheco LS, Lacey JV, Martinez ME, et al. Sugar-sweetened beverage in- take and cardiovascular disease risk in the California teachers study. J Am Heart Assoc. 2020;9:e014883. 46. Von Philipsborn P, Stratil JM, Burns J, et al. Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health. Cochrane Database of Syst Rev. 2019;6:CD012292. 47. De Souza RJ, Mente A, Maroleanu A, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ. 2015;351:h3978. 48. Bhatti JS, Kaur S, Bhatti GK, et al. Genetic susceptibility of vitamin D receptor (VDR) gene variants (BsmI, TaqI and FokI) to coronary artery disease in Asian Indians. Endocr Pract. 2019;25:6A. 49. De Metrio M, Milazzo V, Rubino M, et al. Vitamin D plasma levels and inhospital and 1-year outcomes in acute coronary syndromes: a prospective study. Medicine (Baltim). 2015;94:e857. 50. Correia LC, Sodre F, Garcia G, et al. Relation of severe deficiency of vitamin D to cardiovascular mortality during acute coronary syndromes. Am J Cardiol. 2013;111:324–327. 51. Zhang Y, Tan H, Tang J, et al. Effects of vitamin D supplementation on prevention of type 2 diabetes in patients with prediabetes: a systematic review and meta-analysis. Diabetes Care. 2020;43:1650–1658. 52. Kim H, Caulfield LE, Rebholz CM. Healthy plant-based diets are as- sociated with lower risk of all-cause mortality in US adults. J Nutr. 2018;148:624–631. 4.2.2. Mental Health Conditions 1. Celano CM, Suarez L, Mastromauro C, et al. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2013;6:498–504. 2. Kim J-M, Stewart R, Kang H-J, et al. Long-term cardiac outcomes of depression screening, diagnosis and treatment in patients with acute coronary syndrome: the DEPACS study. Psychol Med. 2021;51:964–974. 3. Kronish IM, Moise N, Cheung YK, et al. Effect of depression screening after acute coronary syndromes on quality of life: the CODIACS-QoL randomized clinical trial. JAMA Intern Med. 2020;180:45–53. 4. Vaccarino V, Badimon L, Bremner JD, et al. Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation. Eur Heart J. 2020;41:1687–1696. 5. Kim JM, Stewart R, Lee YS, et al. Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial. JAMA. 2018;320:350–358. 6. Smolderen KG, Buchanan DM, Gosch K, et al. Depression treatment and 1-year mortality after acute myocardial infarction: insights from the TRI- UMPH registry (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status). Circulation. 2017;135:1681–1689. 7. Levine GN, Cohen BE, Commodore-Mensah Y, et al. Psychological health, well-being, and the mind-heart-body connection: a scientific statement from the American Heart Association. Circulation. 2021;143:e763–e783. 8. World Health Organization. Mental health: strengthening our response. Accessed November 15, 2021. https://www.who.int/news-room/fact-sheets/ detail/mental-health-strengthening-our-response. 9. Masters KS, Shaffer JA, Vagnini KM. The impact of psychological functioning on cardiovascular disease. Curr Atheroscler Rep. 2020;22:51. 10. Celano CM, Huffman JC. Depression and cardiac disease: a review. Cardiol Rev. 2011;19:130–142. 11. Thombs BD, Bass EB, Ford DE, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med. 2006;21:30–38. 12. Smaardijk VR, Maas A, Lodder P, et al. Sex and gender-stratified risks of psychological factors for adverse clinical outcomes in patients with ischemic heart disease: a systematic review and meta-analysis. Int J Cardiol. 2020;302:21–29. 13. Larrabee Sonderlund A, Thilsing T, Sondergaard J. Should social disconnectedness be included in primary-care screening for cardiometabolic disease? A systematic review of the relationship between everyday stress, social connectedness, and allostatic load. PLoS One. 2019;14:e0226717. 14. Kim J, Yang KH, Choi AR, et al. Healthcare quality assessments: no guarantees of same outcomes for different socio-economic stroke patients. Int J Qual Health Care. 2021;33:mzab081. 15. Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005;62:792–798. 16. Gulliksson M, Burell G, Vessby B, et al. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular Downloaded from http://ahajournals.org by on October 7, 2026